Women’s and Sexual Health
Statistics
- Sexually transmitted infections are on the rise in the US
- 1 in 2 sexually active persons will contract an STI by age 25
- Many patients harboring dangerous STIs are asymptomatic
- CDC recommends routine screening of all persons with high risk behavior
What are the benefits to the patient?
- Sensitive and accurate testing to diagnose sexually transmitted infections in men and women
- Rapid and accurate results identify range of STIs from a single sample
- Molecular testing has become the gold standard in providing the highest level of diagnostic sensitivity and specificity.
- Single swab approach eliminates the need for multiple collections.
- Eliminate painful urethral swabs by using urine specimen for patients with suspected urethritis.
- Able to test for bacterial, viral, and protozoan STIs from single sample.
- Most women will suffer from a vaginal infection in their lifetime
- >95%
- 27-41% of women of child-bearing age suffer from chronic bacterial vaginosis (BV)
- High rate of treatment failure
- Infectious etiology is complex
- Sexually transmitted infections
- Loss of protective flora
- Rise of nonresident flora
- Chronic transitional states prevent return to normal
- MCL’s comprehensive panel of diagnostic tests allow providers flexibility to be more specific or broad range depending upon scenario
- High rate of occurrence and recurrence highlights need for actionable information by providers
